| Entry |
|
|---|
| Name |
Cixutumumab (USAN)
|
|---|
| Formula |
C6500H10052N1724O2036S44
|
|---|
| Exact mass |
146244.3741
|
|---|
| Mol weight |
146334.5521
|
|---|
| Activity |
Treatment of solid tumors
|
|---|
| Comment |
Monoclonal antibody
|
|---|
| Target |
insulin-like growth factor 1 receptor [HSA: 3480] [KO: K05087] |
|---|
| Pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cytokine receptors
Receptor tyrosine kinase
RTK class II (Insulin receptor family)
insulin-like growth factor 1 receptor [HSA:3480] [KO:K05087]
Cixutumumab
D09328 Cixutumumab (USAN)
 |
|---|
| Other DBs |
|
|---|
